Key result
CONFIRM score improves all-cause mortality prediction by ~6% over NCEP ATP III in CCTA patients.
Why the study?
Does the CONFIRM score improve prediction of all-cause mortality compared to traditional clinical risk scores in patients undergoing CCTA?
Cohort (n=15,219)
Yes
Does the CONFIRM score improve prediction of all-cause mortality compared to traditional clinical risk scores in patients undergoing CCTA?
Effect estimate: categorical NRI 0.06 (95% CI 0.02-0.10)
p-value: p=0.005
The CONFIRM score derived from CCTA provides significantly better long-term prediction of all-cause mortality compared to traditional clinical risk scores.
May refine mortality risk stratification on CCTA; leaves open prospective validation before practice change.
AIMS: To investigate the long-term performance of the CONFIRM score for prediction of all-cause mortality in a large patient cohort undergoing coronary computed tomography angiography (CCTA). METHODS AND RESULTS: Patients with a 5-year follow-up from the international multicentre CONFIRM registry were included. The primary endpoint was all-cause mortality. The predictive value of the CONFIRM score over clinical risk scores (Morise, Framingham, and NCEP ATP III score) was studied in the entire patient population as well as in subgroups. Improvement in risk prediction and patient reclassification were assessed using categorical net reclassification index (NRI) and integrated discrimination improvement (IDI). During a median follow-up period of 5.3 years, 982 (6.5%) of 15 219 patients died. The CONFIRM score outperformed the prognostic value of the studied three clinical risk scores (c-indices: CONFIRM score 0.696, NCEP ATP III score 0.675, Framingham score 0.610, Morise score 0.606; c-index for improvement CONFIRM score vs. NCEP ATP III score 0.650, P < 0.0001). Application of the CONFIRM score allowed reclassification of 34% of patients when compared with the NCEP ATP III score, which was the best clinical risk score. Reclassification was significant as revealed by categorical NRI (0.06 with 95% CI 0.02 and 0.10, P = 0.005) and IDI (0.013 with 95% CI 0.01 and 0.015, P < 0.001). Subgroup analysis revealed a comparable performance in a variety of patient subgroups. CONCLUSIONS: The CONFIRM score permits a significantly improved prediction of mortality over clinical risk scores for >5 years after CCTA. These findings are consistent in a large variety of patient subgroups.
No takes yet. Share an insight, caveat, or question.
Deseive et al. (2016) conducted a cohort in Patients undergoing coronary computed tomography angiography (CCTA) (n=15,219). CONFIRM score vs. Clinical risk scores (Morise, Framingham, and NCEP ATP III score) was evaluated on All-cause mortality (categorical NRI 0.06, 95% CI 0.02-0.10, p=0.005). The CONFIRM score significantly improved the prediction of all-cause mortality over the NCEP ATP III score in patients undergoing CCTA (categorical NRI 0.06; 95% CI 0.02-0.10; P=0.005).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: